Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.

This study has been withdrawn prior to enrollment.

Sponsor:

Information provided by:

Novartis

ClinicalTrials.gov Identifier:

NCT00242528

First received: October 9, 2005

Last updated: November 20, 2009

Last verified: November 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given